Cupid

Healthcare products manufacturer Cupid Ltd on Thursday reported over two-fold increase in its net profit to Rs 24 crore for the second quarter ended September 30. The company had reported a net profit of Rs 10 crore in the July-September quarter of last year. Total income increased to Rs 90 crore for the second quarter as against Rs 47 crore in the year-ago period, the company said in a statement. "With capacity expansion and smarter procurement, we are removing execution bottlenecks and building a durable growth engine. We remain on track for our Rs 335 cr topline in FY26 and will reassess guidance during H2 in light of the constructive developments across our portfolio," Cupid Chairman and MD Aditya Kumar Halwasiya noted. The second half of FY26 is expected to be stronger than the first half, driven by strong order visibility and improving execution, it stated. The company also expects to deliver net profit of over Rs 100 crore for the year, it added. Shares of the company were

Health and wellness products maker Cupid Ltd expects its annual revenue to cross Rs 115 crore mark from the South African market, as the company has bagged the maximum allocation in the African country's procurement programme for contraceptive products, according to a statement. The procurement is expected to commence from December 2025 and Cupid is coordinating closely with South African approved distributors for phased roll out, the company said in a statement. Cupid has secured a leading position in South Africa's five-year (20252030) national procurement program for female and male condoms. The total financial visibility (annual and indicative) for Cupid is USD 12.98 million (Rs 115 crore), it said further. Aditya Kumar Halwasiya, Chairman and Managing Director, Cupid Limited, stated, "These allocations place Cupid at the forefront of South Africa's prevention program. We're working on the ground with our customers and the public-health system to ensure a smooth start in Decembe

The buying on the counter came after the company's promoter Aditya Kumar Halwasiya bought an additional 1 million share or 0.37 per cent stake in Cupid through an open market transaction

Health products maker Cupid Ltd on Wednesday said it expects a revenue of more than Rs 100 crore to accrue from exports in the coming quarters. The international order book will be executed in the second and third quarters of 2025-26, the contraceptive products manufacturer said in a statement. The current B2B export order book is at USD 11.50 million which is equivalent to Rs 100 crore plus, across three key products segments," Cupid said in a statement. "These orders are from international government tenders in South Africa, Tanzania, and Kenya, as well as from international agencies WHO/UNFPA, NGOs like MSI and PSI," the company said. Cupid Ltd also anticipates significant orders from Brazil having secured L1 in the recent tender comprising 6.25 million pieces valued at approximately Rs 40 crore with additional future orders expected from that country, it said. The company also expects orders from Tanzania, one of the largest markets in East Africa, in Q2 and Q3 of FY26. These

Stocks to watch on Tuesday, April 09, 2024: Tata Motors JLR sales rose 11% in Q4; Bain Capital to sell balance stake in Axis Bank; FADA warns of slower retail auto sales.

The board of directors of Cupid is scheduled to meet on January 23, 2024, to consider and approve Q3 results, proposal of stock split, bonus issue and raising of funds.

Shares of Cupid were locked in the 10-per cent upper circuit at Rs 818 on the BSE on Friday at 02:12 PM

The stock was up 9% to Rs 315 after the company said the board will meet on January 05, to consider the proposal for raising funds through issue of securities.